VHL: NEW DRUG FOR GENETIC DISEASE SHRINKS TUMORS

Von Hippel-Lindau disease is an inherited condition named after the two European scientists who discovered it. VHL puts people at higher risk of cancerous and benign tumors in multiple organs, including the kidneys, pancreas, spine, and brain. Until last year, surgical removal of the tumors was the only treatment, but now, a newly approved therapy may help people with VHL avoid repeated, dangerous surgeries.